V Square Quantitative Management LLC Boosts Stock Position in CVS Health Co. (NYSE:CVS)

V Square Quantitative Management LLC increased its position in shares of CVS Health Co. (NYSE:CVS) by 4.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 12,950 shares of the pharmacy operator’s stock after purchasing an additional 505 shares during the quarter. V Square Quantitative Management LLC’s holdings in CVS Health were worth $765,000 as of its most recent filing with the SEC.

Other large investors have also recently made changes to their positions in the company. International Assets Investment Management LLC grew its holdings in CVS Health by 11.4% in the 4th quarter. International Assets Investment Management LLC now owns 16,744 shares of the pharmacy operator’s stock valued at $1,322,000 after buying an additional 1,715 shares in the last quarter. Tennessee Valley Asset Management Partners purchased a new stake in CVS Health in the 4th quarter valued at $50,000. Koshinski Asset Management Inc. grew its holdings in CVS Health by 9.1% in the 4th quarter. Koshinski Asset Management Inc. now owns 7,939 shares of the pharmacy operator’s stock valued at $627,000 after buying an additional 663 shares in the last quarter. Simplicity Solutions LLC grew its holdings in CVS Health by 9.2% in the 4th quarter. Simplicity Solutions LLC now owns 32,416 shares of the pharmacy operator’s stock valued at $2,560,000 after buying an additional 2,721 shares in the last quarter. Finally, Louisiana State Employees Retirement System acquired a new position in shares of CVS Health in the 4th quarter valued at $6,135,000. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on CVS shares. Evercore ISI decreased their price target on CVS Health from $65.00 to $62.00 and set an “outperform” rating on the stock in a research note on Thursday, August 8th. The Goldman Sachs Group decreased their price target on CVS Health from $85.00 to $74.00 and set a “buy” rating on the stock in a research note on Thursday, May 2nd. TD Cowen lowered CVS Health from a “buy” rating to a “hold” rating and decreased their price target for the company from $99.00 to $59.00 in a research note on Tuesday, May 7th. Barclays decreased their target price on CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 8th. Finally, Leerink Partnrs lowered CVS Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, May 1st. Twelve equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $73.24.

CVS Health Stock Up 0.4 %

Shares of CVS traded up $0.23 during mid-day trading on Wednesday, reaching $56.05. The company’s stock had a trading volume of 3,070,930 shares, compared to its average volume of 11,448,567. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The stock has a market cap of $70.36 billion, a PE ratio of 9.81, a price-to-earnings-growth ratio of 0.57 and a beta of 0.52. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61. The company’s 50 day moving average is $59.28 and its 200 day moving average is $65.90.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The business had revenue of $91.23 billion for the quarter, compared to the consensus estimate of $91.41 billion. During the same quarter in the prior year, the business posted $2.21 EPS. The business’s revenue for the quarter was up 2.6% on a year-over-year basis. Equities analysts anticipate that CVS Health Co. will post 7 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, August 1st. Shareholders of record on Monday, July 22nd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.75%. The ex-dividend date was Monday, July 22nd. CVS Health’s dividend payout ratio (DPR) is 46.75%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.